Evaluation of A Fish Hydrolysate Protein-Superoxide Dismutase Combination (Anxivet®) For Cat Behaviour: A Pet Owners' Perspective

This survey assessed the effectiveness of a combination of hydrolysed fish proteins and melon superoxide dismutase in reducing inappropriate behaviours in cats. Forty-eight privately-owned cats with abnormal emotional behaviour, as reported by their owners, were administered a complementary feed (Anxivet®, MP Labo, France) once daily for 28 days. Owners completed questionnaires before (D0) and after (D2, D7, D14, and D28) initiating the product, assessing animal behaviour, interaction with surroundings, and discomfort levels. They also evaluated product effectiveness, satisfaction, and ease of administration. By D28, 12 out of 24 behavioural signs showed improvement, with a significant decrease in excessive mewing (p = 0.0485). Enhanced interaction with surroundings was observed in 19%, 29%, and 34% of cats on D2, D7, and D14, respectively, with significant improvement from D2 to D14 (p < 0.025). Discomfort decreased in 23%, 30%, and 34% of cats on D2, D7, and D14, respectively, with a significant difference between D2 and D14 (p < 0.01). Owners rated product efficacy as 7.7/10 at D28, with satisfaction scores increasing from 6.4 at D2 to 7.4 at D14 (p < 0.0339). This survey suggests the tested combination reduces cats' discomfort levels, though further confirmation via controlled randomised studies is warranted.